[Corrigendum] 5‑bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2‑one induces apoptosis in T24 human bladder cancer cells

Guo-Qiang Yu1, Zhong-Ling Dou1, Zhao-Hui Jia1

  • 1Department of Urological Surgery, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.

Molecular Medicine Reports
|December 31, 2016
PubMed

Insights

This correction clarifies the effects of 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one (BHP) on T24 bladder carcinoma cells. The original Figure 1 erroneously duplicated control data, but the study

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Bladder carcinoma is a significant health concern.
  • Investigating novel compounds for cancer treatment is crucial.

Purpose of the Study:

  • To investigate the effects of 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one (BHP) on T24 bladder carcinoma cells.
  • To assess the impact of BHP on cell morphology and viability.

Main Methods:

  • T24 bladder carcinoma cells were treated with varying concentrations of BHP.
  • Cell morphology and viability were analyzed.
  • Original data for Figure 1 was re-examined.

Main Results:

  • A correction to Figure 1 is presented, showing the accurate effects of 10 µM BHP.
  • The original Figure 1 contained duplicated control data.
  • The error did not alter the study's conclusions.

Conclusions:

  • The corrected data accurately reflects the impact of BHP on T24 bladder carcinoma cells.
  • The study's original conclusions remain valid despite the data error.